Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High?

Immunocore Holdings PLC Sponsored ADR (IMCR) closed the last trading session at $36.05, gaining 12.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $62.13 indicates a 72.3% upside potential.The average comprises 15 short-term price targets ranging from a low of $24.00 to a high of $100.00, with a standard deviation of $22.46. While the lowest estimate indicates a decline of 33.4% ...